Pfizer Raises Quarterly Dividend to 0.43, Offering 6.66 percent Yield
| 0P00007138 | CAD 54.94 0.18 0.33% |
About 61% of RBC Sciences' investor base is looking to short. The analysis of overall sentiment of trading RBC sciences biologiques fund suggests that many investors are alarmed at this time. The current market sentiment, together with RBC Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use RBC sciences biologiques fund news signals to limit their universe of possible portfolio assets.
RBC |
Pfizer Inc. raised its quarterly cash dividend to 0.43 per share for the first quarter of 2025. The board approval for this increase provides
Read at gurufocus.com
 |
RBC Sciences Fundamental Analysis
We analyze RBC Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC Sciences based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
RBC Sciences is rated below average in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
RBC sciences biologiques Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RBC Sciences fund to make a market-neutral strategy. Peer analysis of RBC Sciences could also be used in its relative valuation, which is a method of valuing RBC Sciences by comparing valuation metrics with similar companies.
Peers
RBC Sciences Related Equities
| 0P00007138 | RBC Sciences | 0.33 |
| ||
| 0P00018PVY | RBC European | 1.19 |
| ||
| 0P00007065 | RBC Mondial | 2.28 |
| ||
| 0P00007061 | RBC Canadian | 3.75 |
| ||
| 0P00012UCU | RBC Global | 9.73 |
| ||
| 0P000077P2 | RBC Dividend | 13.84 |
|
Other Information on Investing in RBC Fund
RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |